About half of health care workers positive for COVID-19 by serology have no symptoms
Can This Coronavirus Stock Soar 230%? 5-Star Analyst Thinks So
Neutralizing antibodies in the battle against COVID-19
NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools
US snaps up first supplies of Regeneron’s COVID-19 antibody
How coronavirus affects the brain
GSK, Medicago Forge Agreement to Develop COVID-19 Vaccine
Exclusive: Moderna spars with U.S. scientists over COVID-19 vaccine trials
Corvus Shoots Up 115% On Start Of Novel Immunotherapy Study In Covid-19 Patients
Rare neurological disorder, Guillain-Barre Syndrome, linked to COVID-19
Analyst Sounds the Valuation Alarm Bell on Inovio’s Hot Stock
S&P Futures Surge As Chinese Stocks Explode Higher
How Can Economists Help?
Newer, More Dominant COVID-19 Variant Is More Infectious in the Lab
Pfizer/BioNTech’s COVID-19 vaccine neutralises virus in early study
Reopening America: The value of testing and modeling
Futures Surge On Even More "Optimism" Ahead Of Payrolls
Which drugs and therapies are proven to work, and which ones don't, for COVID-19?
Has Inovio Stock Surged Enough for Now? This Analyst Says Yes
Pfizer, BioNTech Rise On ‘Positive’ Early Data Of Potential Coronavirus Vaccine
FDA Sets Bar for COVID-19 Vaccine Approval at 50 Percent Effectiveness
Designing anew: Radical COVID-19 drug development approach shows promise
Inovio Presents ‘Positive’ Early Data For Covid-19 Vaccine Candidate; Shares Plunge 12%
Coronavirus: the antibody drugs few people have been discussing – until now
Even in the worst COVID-19 cases, the body launches immune cells to fight back
Sanford Burnham Prebys enters research agreement with Lilly for COVID-19 antibody research
Six Downside Risks
Market Corrects As COVID Cases Surge 06-26-20
Brazilian startup seeks to develop a wholly indigenous COVID-19 diagnostic test
Coronavirus pharma news roundup – 26/06/20